» Articles » PMID: 19563404

Japanese Herbal Medicine in Functional Gastrointestinal Disorders

Overview
Date 2009 Jul 1
PMID 19563404
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Management of functional gastrointestinal disorders is hindered by both poor efficacy and adverse effects of traditional pharmacological therapy. Herbal medicine may be an attractive alternative based on the perception of its 'natural' approach and low risk of side effects; however, the lack of standardization of drug components has limited the ability to perform rigorous clinical studies in Western countries. Japanese herbal medicine (JHM) is a standardized form of herbal medicine with regards to the quality and quantities of ingredients. While extensively studied and widely used in Asia, there is a paucity of data upon which physicians in other parts of the world may draw conclusions regarding the effectiveness of herbal medicine for gastrointestinal disorders. The aim of this study was to summarize the most recent developments in JHM for treatment of functional gastrointestinal disorders. Animal and human studies were systematically reviewed to identify published data of JHM used for treatment of gastrointestinal disorders. The herbal components of JHM were examined. Results describing the physiological and clinical effects of JHM were abstracted, with an emphasis on functional gastrointestinal disorders. JHM are associated with a variety of beneficial physiological on the gastrointestinal system. Patient-based clinical outcomes are improved in several conditions. Rikkunnshi-to reduces symptoms and reverses physiological abnormalities associated with functional dyspepsia, while dai-kenchu-to improves symptoms of postoperative ileus and constipation in children. This updated summary of JHM in the field of gastrointestinal disorders illustrates the potential for herbal medication to serve a valuable role in the management of patients with functional gastrointestinal disorders.

Citing Articles

Role of Ginger in management of nausea among patients receiving chemotherapy.

Syed Z, Fahim A, Safdar M, Imtiaz R Pak J Med Sci. 2024; 40(9):2036-2040.

PMID: 39416604 PMC: 11476162. DOI: 10.12669/pjms.40.9.8739.


Herbal medicine, , for functional dyspepsia: a systematic review and meta-analysis.

Kim K, Ko S, Cho S, Kim J, Park J Front Pharmacol. 2023; 14:1130257.

PMID: 37274096 PMC: 10235465. DOI: 10.3389/fphar.2023.1130257.


Efficacy of Natural Formulation Containing Activated Charcoal, Calcium Sennosides, Peppermint Oil, Fennel Oil, Rhubarb Extract, and Purified Sulfur (Nucarb®) in Relieving Constipation.

Ali R, Irfan M, Akram U, Vaince M, Hassan K, Maqsood A Cureus. 2021; 13(10):e18419.

PMID: 34725578 PMC: 8555919. DOI: 10.7759/cureus.18419.


Interstitial Cells of Cajal: Potential Targets for Functional Dyspepsia Treatment Using Medicinal Natural Products.

Joung J, Choi S, Son C Evid Based Complement Alternat Med. 2021; 2021:9952691.

PMID: 34306162 PMC: 8263244. DOI: 10.1155/2021/9952691.


Efficacy and Safety of Yukgunja-Tang for Patients with Cancer-related Anorexia: A Randomized, Controlled Trial, Pilot Study.

Ko M, Song S, Ha S, Lee J, Yoon S, Park J Integr Cancer Ther. 2021; 20:15347354211019107.

PMID: 34032151 PMC: 8371029. DOI: 10.1177/15347354211019107.


References
1.
Takasuna K, Kasai Y, Kitano Y, Mori K, Kobayashi R, Hagiwara T . Protective effects of kampo medicines and baicalin against intestinal toxicity of a new anticancer camptothecin derivative, irinotecan hydrochloride (CPT-11), in rats. Jpn J Cancer Res. 1995; 86(10):978-84. PMC: 5920598. DOI: 10.1111/j.1349-7006.1995.tb03010.x. View

2.
Efficace F, Horneber M, Lejeune S, van Dam F, Leering S, Rottmann M . Methodological quality of patient-reported outcome research was low in complementary and alternative medicine in oncology. J Clin Epidemiol. 2006; 59(12):1257-65. DOI: 10.1016/j.jclinepi.2006.03.006. View

3.
Mori K, Kondo T, Kamiyama Y, Kano Y, Tominaga K . Preventive effect of Kampo medicine (Hangeshashin-to) against irinotecan-induced diarrhea in advanced non-small-cell lung cancer. Cancer Chemother Pharmacol. 2003; 51(5):403-6. DOI: 10.1007/s00280-003-0585-0. View

4.
Hashimoto K, Satoh K, Murata P, Makino B, Sakakibara I, Kase Y . Components of Panax ginseng that improve accelerated small intestinal transit. J Ethnopharmacol. 2002; 84(1):115-9. DOI: 10.1016/s0378-8741(02)00284-2. View

5.
Talley N . Functional gastrointestinal disorders as a public health problem. Neurogastroenterol Motil. 2008; 20 Suppl 1:121-9. DOI: 10.1111/j.1365-2982.2008.01097.x. View